The Assembly Biosciences Inc. (ASMB) Stake Held by Rock Springs Capital Management LP

The Assembly Biosciences Inc. (ASMB) Stake Held by Rock Springs Capital Management LP

Rock Springs Capital Management LP continued to hold its stake in shares of Assembly Biosciences Inc. (NASDAQ:ASMB) during the third quarter, Holdings Channel reports. The fund owned 390,000 shares of the biopharmaceutical company’s stock at the end of the third quarter. Rock Springs Capital Management LP’s holdings in Assembly Biosciences were worth $2,812,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of ASMB. Northern Trust Corp raised its stake in shares of Assembly Biosciences by 2.3% in the third quarter. Northern Trust Corp now owns 40,451 shares of the biopharmaceutical company’s stock valued at $292,000 after buying an additional 901 shares during the period. BlackRock Institutional Trust Company N.A. raised its stake in shares of Assembly Biosciences by 0.8% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 267,699 shares of the biopharmaceutical company’s stock valued at $1,930,000 after buying an additional 2,116 shares during the period. National Asset Management Inc. raised its stake in shares of Assembly Biosciences by 15.0% in the second quarter. National Asset Management Inc. now owns 22,714 shares of the biopharmaceutical company’s stock valued at $127,000 after buying an additional 2,957 shares during the period. Thompson Davis & CO. Inc. raised its stake in shares of Assembly Biosciences by 2,857.2% in the third quarter. Thompson Davis & CO. Inc. now owns 14,786 shares of the biopharmaceutical company’s stock valued at $107,000 after buying an additional 14,286 shares during the period. Finally, Paloma Partners Management Co purchased a new stake in shares of Assembly Biosciences during the second quarter valued at about $314,000. 64.53% of the stock is owned by hedge funds and other institutional investors.

Shares of Assembly Biosciences Inc. (NASDAQ:ASMB) traded up 3.54% during midday trading on Thursday, reaching $18.99. The company’s stock had a trading volume of 123,722 shares. The company’s 50-day moving average price is $13.12 and its 200-day moving average price is $9.77. The company’s market cap is $327.10 million. Assembly Biosciences Inc. has a 12 month low of $4.33 and a 12 month high of $19.49.

Assembly Biosciences Company Profile

Assembly Biosciences, Inc is a biotechnology company. The Company is engaged in developing approximately two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral biological therapeutics, which are designed to restore health to a dysbiotic microbiome.

Want to see what other hedge funds are holding ASMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Assembly Biosciences Inc. (NASDAQ:ASMB).

Related posts

Leave a Comment